Researchers say if their results are confirmed through further study they are optimistic the approach could be used to treat ...

In their effort to answer a decades-old biological question about how the hepatitis B virus (HBV) is able to establish infection of liver cells, researchers have identified a vulnerability that opens ...

In their effort to answer a decades-old biological question about how the hepatitis B virus (HBV) is able to establish infection of liver cells, research led by Memorial Sloan Kettering Cancer Center ...

The trial was tailored to evaluate the therapy at multiple ascending dose levels, with three dose administrations per level.

With several drugs in use that inhibit the hepatitis B virus polymerases (nucleos(t)ide analogues (or NUCs)), some argue that new direct-acting antiviral drugs, and new NUCs in particular ...

Although much research on the mechanisms of portal hypertension has focused on liver fibrosis, less attention has been given to the role of intrahepatic and extrahepatic ... Chronic hepatitis, ...

Heart disease and stroke remained the leading causes of death in the U.S. in 2022, outpacing the number of combined deaths from cancer and accidental deaths, according to the American Heart ...

A multicenter, prospective observational study of chemotherapy in elderly patients with biliary tract cancer. This is an ASCO Meeting Abstract from the 2025 ASCO Gastrointestinal Cancers Symposium.

"We were very concerned," Vanderwolf told Shift. "We had heard about the disease and what it was doing in the northeastern United States." Vanderwolf said the fungus — Pseudogymnoascus ...

Romanò L, Paladini S, Galli C, Raimondo G, Pollicino T, Zanetti AR. Hepatitis B vaccination. Hum Vaccin Immunother. 2015;11(1):53-57. doi:10.4161/hv.34306 Centers for Disease Control and Prevention.

British Columbia's attorney general says the B.C. Supreme Court has certified the province's class-action lawsuit against opioid manufacturers and distributors. Niki Sharma says B.C. can now ...

Screening for hepatitis B virus is the first crucial step for patients starting immunosuppressive medications, noted guideline authors. In March 2023, the U.S. Center for Disease Control and ...